Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

9th International Conference on Food Pathogen and Food Safety

Paris, France

Hisham R. IBRAHIM


Hisham R. IBRAHIM

Kagoshima University, Japan

Biography

Hisham Ibrahim is currently a Professor of Food Biochemistry and Structural Biology at Kagoshima University (Japan). He obtained his PhD degree in Structural Biology and Protein Engineering from Tottori University (Japan) in 1993. He worked as a research group leader in Taiyo Kagaku Central Research Institute (Mie, Japan) from 1993-1995. In 1995, he was appointed to the Department of Food Science and Biotechnology, Kagoshima University from Assistant Professor to full Professor. Dr. Ibrahim pursued research at the Center for Antimicrobial Research (CAR), California State Polytech University, Los Angeles (USA) as visiting scientist from 2000-2001. He is a conference organizer and chair in the American Chemical Society (ACS) and the American Oil Chemists Society (AOCS). He is an Editorial Board of Journal of Developing Drugs, Journal of Insights in Medical Science, Journal of Functional Foods in Health and Disease, and Journal of Food Science and Engineering.

  His research focuses most on the discovery and development of bioactive peptides and proteins with therapeutic potential to fight infections, cancers and inflammatory diseases. Other research relates to the development of novel drug-delivery system for specific targeting of drugs into their intracellular targets by using food proteins combined with nanotechnology. Dr. Ibrahim work could lead to new cures for cancers, inflammatory and complicated infectious diseases.

  He succeeded in introducing several scientific findings in reputable international journals and in well-recognized books.

Abstract

Abstract : Novel health potential of bioactive peptides from egg albumin